TickerFacts.

Vivos Inc (RDGL): Capital Expenditures

Annual figures by period end, from SEC filings.

$103.2K
Year ended 2025-12-31
2011-12-31: $02012-12-31: $14.8K2013-12-31: $02025-12-31: $103.2K$103.2K
2011-12-31 Capital Expenditures (USD) 2025-12-31
Period endedCapital ExpendituresChange YoYSource filing
2025-12-31$103.2Kn/a2026-03-31, From 2025-01-01
No annual figure between 2013-12-31 and 2025-12-31.
2013-12-31$0-100.0%2014-03-31, From 2013-01-01
2012-12-31$14.8Kn/a2014-03-31, From 2012-01-01
2011-12-31$0n/a2013-03-29, From 2011-01-01

Capital Expenditures at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCapital ExpendituresChange YoY
Vivos Inc (RDGL)2025-12-31$103.2Kn/a
QTREX Quantum Ltd. (QTEX)2025-12-31$103.0K-37.2%
Pulse Biosciences, Inc. (PLSE)2025-12-31$315.0K+152.0%
Co-Diagnostics, Inc. (CODX)2025-12-31$700.0K-6.5%
Harvard Apparatus Regenerative Technology, Inc. (HRGN)2024-12-31$0-100.0%
Flyte Aviation, Inc. (VJET)2025-12-31$17.0K-74.6%
Sintx Technologies, Inc. (SINT)2025-12-31$185.0K-73.2%
RenovoRx, Inc. (RNXT)2025-12-31$2.0K-83.3%
PetVivo Holdings, Inc. (PETV)2026-03-31$7.7K-87.8%

Compare RDGL, QTEX, PLSE, CODX side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗